GO
Loading...

Most Popular Video

Stock Pops & Drops: DNKN, WTW, MBLY & CZR  Thu, 5 Mar '15 | 5:45 PM ET

The Fast Money traders take a look at today's biggest market movers.

How will Pharmacyclics complement AbbVie?  Thu, 5 Mar '15 | 5:23 PM ET

Sachin Shah, merger arbitrage strategist at Albert Fried and Company, discusses why AbbVie's decision to buy Pharmacyclics for about $21 billion is a "longer-dated" move.

5 big bank trades  Thu, 5 Mar '15 | 5:00 PM ET

The "Fast Money" traders give you their top 5 bank trades.

The Federal Reserve building is shown in Washington.

CNBC's Kayla Tausche reports on the results of the Fed's bank stress test. All 31 banks have cleared capital requirement levels and had sufficient capital before shareholder payout. Perspective, with Jack Mohr, thestreet.com, and Jeff harte, Sandler O'Neill.

Commodities tomorrow: Volatility continues  Thu, 5 Mar '15 | 4:00 PM ET

CNBC's Jackie DeAngelis discusses the day's activity in the commodities markets. WTI was down and Brent was up, on the day. Today's catalysts: Profit taking and a lowered China growth target.

Cuban: Private tech investors beware  Thu, 5 Mar '15 | 3:52 PM ET
Mark Cuban

Dallas Mavericks owner Mark Cuban said in a recent blog this tech bubble is worse than the one in 2000. Cuban discusses the lack of liquidity in this current tech market; the IPO market, angel investors and crowd funding.

Cramer: A stock roaring on execution  Thu, 5 Mar '15 | 6:00 PM ET

This stock is crushing it, and "Mad Money" host Jim Cramer says it's all about execution.

Hundreds of drivers stranded  Thu, 5 Mar '15 | 1:05 PM ET

Hundreds of drivers in Kentucky are stranded on the highway, reports CNBC's Tyler Mathisen.

Yamada makes bullish case for stocks  Thu, 5 Mar '15 | 1:10 PM ET

Master technician Louise Yamada offers her take on the market. Trading the S&P now, with CNBC's Jackie DeAngelis and the Futures Now Traders.

Delta jet slides off runway at LGA  Thu, 5 Mar '15 | 11:50 AM ET

An update on the Delta airlines flight 1086 out of Atlanta that skidded off the runway at LaGuardia Airport in New York, with "Squawk Alley."

ExxonMobil CEO Rex Tillerson shares his thoughts on Warren Buffett's decision to sell Exxon shares and what it means for the stock.

Wayfair CEO: Marketing investment working  Thu, 5 Mar '15 | 8:35 AM ET

Niraj Shah, Wayfair CEO, discusses his company's earnings beat, IPO, and making money in e-commerce. And Bill George, Harvard business professor, weighs in.

Bigger Apple iPad delayed?  Thu, 5 Mar '15 | 9:00 AM ET

CNBC's Dominic Chu and RBC Capital Markets analyst Amit Daryanani discuss concerns that the production of Apple's 12.9-inch iPad will be delayed.

CNBC's Jim Cramer says Exxon thinks further out than five or ten years. And Bill George, Harvard business professor, weighs in.

ECB's bond-buying to begin March 9th  Thu, 5 Mar '15 | 8:45 AM ET

Jim Iuorio, TJM Institutional Service, and CNBC's Steve Liesman and Rick Santelli, weigh in on the ECB's rate and monetary policy decision.

Oil's supply and demand dilemma  Thu, 5 Mar '15 | 8:04 AM ET

ExxonMobil CEO Rex Tillerson, discusses how the oil glut is impacting energy prices and creating storage problems.

ECB keeps rates unchanged  Thu, 5 Mar '15 | 7:45 AM ET

The European Central Bank has announced this month's rate decision. CNBC's Annette Weisbach reports.

Move over GoPro  Thu, 5 Mar '15 | 5:45 AM ET
Los Angeles Clippers’ DeAndre Jordan (6) follows through on his slam-dunk over Portland Trail Blazers’ Chris Kaman (35) during an NBA basketball game in Los Angeles, Nov. 8, 2014.

CNBC's Phil Han reports from the Mobile World Congress about how one company is hoping to change the way you watch sporting events.

How McDonald's makes its menu  Wed, 4 Mar '15 | 4:58 PM ET

Choosing which new burgers and fries make the cut is no small task for the world's fast food king. CNBC.com's Katie Little explains how McDonald's creates its menu.

Is your eye the new fingerprint?  Thu, 5 Mar '15 | 8:45 AM ET

CNBC's Phil Han reports on Fujitsu's new iris recognition prototype that was released at this year's Mobile World Congress.

Dream jobs: Best places to work  Thu, 5 Mar '15 | 7:52 AM ET

Alan Murray, Fortune editor, reveals the magazine's annual list of top 100 companies to work for in 2015. This year a tech giant nabs the top spot.

Shaky markets await Draghi, jobs report  Thu, 5 Mar '15 | 6:10 AM ET

Alison Dean, CRT Capital CIO, and Patrick Chovanec, Silvercrest Asset Management, share their thoughts on the market's pullback and whether to expect more volatility ahead.

Another winter storm slams Northeast  Thu, 5 Mar '15 | 6:00 AM ET

Heavy snow and freezing rain is covering much of the East Coast as another winter storm makes its way to parts of New England.

Wall Street on standby ahead of ECB meeting  Thu, 5 Mar '15 | 5:45 AM ET

U.S. stock index futures signaled a flat-to-higher open today ahead of comments by ECB's Mario Draghi, scheduled ahead of Wall Street's open.

Cramer's calling the worst stock of 2015  Wed, 4 Mar '15 | 6:00 PM ET

"Mad Money" host Jim Cramer calls it like he sees it.

Are you a millionaire in the making?  Thu, 5 Mar '15 | 6:40 AM ET

A new study shows investors who are on the road to making millions of dollars are different in several ways from people who are already millionaires.

How will China speed up reforms?  Wed, 4 Mar '15 | 5:51 PM ET

Nicholas Consonery, China analyst at Eurasia Group, expects the National People's Congress to indicate an acceleration in reforms by increasing the power of the central government.

Wall Street's bad day is just 'noise': Pro  Wed, 4 Mar '15 | 5:07 PM ET

Sandy Lincoln, chief market strategist at BMO Asset Management, says the pullback in U.S. stocks may be "noise." He adds that the market still offers good opportunities.

Eswar Prasad, senior professor of Trade Policy at Cornell University, says Beijing is trying to de-emphasize its growth target and send a strong signal that they remain committed to reforms.

Cramer: Best of biotech  Wed, 4 Mar '15 | 6:25 PM ET

Mad Money's Jim Cramer looks at the performance of biotech and leaders in the pharma space.